Picture of Jeisys Medical logo

287410 Jeisys Medical Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Annual cashflow statement for Jeisys Medical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line39.6-21.213,49327,01225,108
Depreciation
Amortisation
Non-Cash Items-93.2-81.211,4279,93112,851
Unusual Items
Other Non-Cash Items
Changes in Working Capital107116-7,129-15,217-9,846
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities53.113.720,26424,76732,376
Capital Expenditures-2,784-13,512-15,018
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-105-1,1058,464-7,587-2,642
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-105-1,1055,681-21,099-17,660
Financing Cash Flow Items-8,219-407-10,376
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-9,3092,018-5,092
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-52.3-1,09116,7005,2929,247